NICOLE BEER: Open Payments
NPI 1407939184 · HOPEWELL, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,910 in 235 payments from 16 companies in 2025. Trend: 2023 $0 · 2024 $2,327 · 2025 $4,910
Food & beverage: $4,910
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 27 | $735 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 25 | $589 |
| ABBVIE INC. | 30 | $490 |
| Lundbeck LLC | 29 | $445 |
| Alkermes, Inc. | 16 | $417 |
| Otsuka America Pharmaceutical, Inc. | 21 | $381 |
| Janssen Pharmaceuticals, Inc | 9 | $336 |
| E.R. Squibb & Sons, L.L.C. | 14 | $311 |
| Vanda Pharmaceuticals Inc. | 12 | $296 |
| Axsome Therapeutics, Inc. | 7 | $274 |
Products named: INGREZZA, CAPLYTA, VRAYLAR, ARISTADA, REXULTI, ABILIFY ASIMTUFII, COBENFY, FANAPT.
Industry payments across VA — which companies pay providers there.
